+370.3%
MRNA vs HTZ
-72.5%
+442.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | HTZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.9% | +9.3% | -10.2% | -3.1% |
| 7D | -3.8% | -27.4% | +23.7% | +3.4% |
| 30D | +16.4% | -11.4% | +27.7% | +18.9% |
| 3M | +310.6% | -33.1% | +343.6% | +338.3% |
| 6M | +370.3% | -73.5% | +443.8% | +418.8% |
| All | +370.3% | -72.5% | +442.8% | +418.8% |
Cumulative growth
Daily Returns
Daily percentage return beside HTZ.
Daily Out/Under-Performance
Portfolio return minus HTZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HTZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded HTZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling